Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis
Clinical trial NCT02576457 · TERMINATED
Trial details
- NCT number
- NCT02576457
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-02
- Primary completion
- 2017-03-15
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.